Citigroup
EDVA

Citigroup’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Citigroup’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– – – 6175
2026
Q1 		– Hold
0
– – – 6336
2025
Q4 		– Sell
-4
Closed -$24 – 5989
2025
Q3 		$35 Buy
+4
New +$35 ﹤0.01% 5869
2022
Q2 		– Sell
-3
Closed -$1K – 6604
2022
Q1 		$1K Buy
+3
New +$1.53K ﹤0.01% 6208

Other funds holding EDVA

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PM
Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return
STA
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $171M AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citigroup's EDVA Position: Q2 2026 in Review

Citigroup held its Endovia Health Sciences, Inc. (EDVA) position steady in Q2 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6175.

Citigroup first reported a position in EDVA in Q1 2022 and has held it in 2 quarters since. The position peaked at $1K in Q1 2022. 18 funds tracked by Wall St. Rank hold EDVA as of Q2 2026.

  • Citigroup held 0 shares of Endovia Health Sciences, Inc. worth $0 as of Q2 2026.
  • Citigroup left its Endovia Health Sciences, Inc. share count unchanged in Q2 2026.
  • Endovia Health Sciences, Inc. made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #6175 holding.
  • Citigroup first reported a position in Endovia Health Sciences, Inc. in Q1 2022 and has held it in 2 quarters since.
  • Citigroup's Endovia Health Sciences, Inc. position peaked at $1K in Q1 2022.
  • 18 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.